Fosmetpantotenate
024PKAN15004
Phase 3 small_molecule terminated
Quick answer
Fosmetpantotenate for Pantothenate Kinase-Associated Neurodegeneration is a Phase 3 program (small_molecule) at Travere Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Travere Therapeutics
- Indication
- Pantothenate Kinase-Associated Neurodegeneration
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated